Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Weight retention and glucose intolerance in early postpartum after gestational diabetes.
Minschart C, Myngheer N, Maes T, De Block C, Van Pottelbergh I, Abrams P, Vinck W, Leuridan L, Driessens S, Mathieu C, Billen J, Matthys C, Laenen A, Bogaerts A, Benhalima K. Minschart C, et al. Among authors: vinck w. Eur J Endocrinol. 2023 May 19:lvad053. doi: 10.1093/ejendo/lvad053. Online ahead of print. Eur J Endocrinol. 2023. PMID: 37204938
Effectiveness of a blended mobile-based lifestyle intervention in women with glucose intolerance after a recent history of gestational diabetes (MELINDA): a 1-year, prospective, multicentre, randomised controlled trial.
Minschart C, Myngheer N, Maes T, De Block C, Van Pottelbergh I, Abrams P, Vinck W, Leuridan L, Driessens S, Mathieu C, Billen J, Matthys C, Laenen A, Bogaerts A, Benhalima K. Minschart C, et al. Among authors: vinck w. EClinicalMedicine. 2024 Mar 8;70:102523. doi: 10.1016/j.eclinm.2024.102523. eCollection 2024 Apr. EClinicalMedicine. 2024. PMID: 38495521 Free PMC article.
Impact of breastfeeding on risk of glucose intolerance in early postpartum after gestational diabetes.
Vanlaer Y, Minschart C, Vrolijk H, Van Crombrugge P, Moyson C, Verhaeghe J, Devlieger R, Vandeginste S, Verlaenen H, Vercammen C, Maes T, Dufraimont E, Roggen N, De Block C, Jacquemyn Y, Mekahli F, De Clippel K, Van Den Bruel A, Loccufier A, Van Pottelbergh I, Myngheer N, Abrams P, Vinck W, Leuridan L, Driessens S, Billen J, Matthys C, Bogaerts A, Laenen A, Mathieu C, Benhalima K. Vanlaer Y, et al. Among authors: vinck w. Front Endocrinol (Lausanne). 2024 Jun 12;15:1374682. doi: 10.3389/fendo.2024.1374682. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38933819 Free PMC article.
One-year postpartum weight retention and glucose intolerance in women with prediabetes after gestational diabetes.
Mievis V, Minschart C, Myngheer N, Maes T, de Block C, Bochanen N, van Pottelbergh I, Abrams P, Vinck W, Leuridan L, Driessens S, Billen J, Matthys C, Laenen A, Bogaerts A, Mathieu C, Benhalima K. Mievis V, et al. Among authors: vinck w. Diabet Med. 2024 Sep;41(9):e15400. doi: 10.1111/dme.15400. Epub 2024 Jul 3. Diabet Med. 2024. PMID: 38958138 Clinical Trial.
Pregnancy-Related Complications in Patients With Fibromuscular Dysplasia: A Report From the European/International Fibromuscular Dysplasia Registry.
Pappaccogli M, Prejbisz A, Ciurică S, Bruno RM, Aniszczuk-Hybiak A, Bracalente I, De Backer T, Debiève F, Delmotte P, Di Monaco S, Jarraya F, Gordin D, Kosiński P, Kroon AA, Maas AHEM, Marcon D, Minuz P, Montagud-Marrahi E, Pasquet A, Poch E, Rabbia F, Stergiou GS, Tikkanen I, Toubiana L, Vinck W, Warchoł-Celińska E, Van der Niepen P, de Leeuw P, Januszewicz A, Persu A; European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI) and the Working Group “Hypertension and the Kidney” of the ESH. Pappaccogli M, et al. Among authors: vinck w. Hypertension. 2020 Aug;76(2):545-553. doi: 10.1161/HYPERTENSIONAHA.120.15349. Epub 2020 Jul 8. Hypertension. 2020. PMID: 32639884
Mobile-Based Lifestyle Intervention in Women with Glucose Intolerance after Gestational Diabetes Mellitus (MELINDA), A Multicenter Randomized Controlled Trial: Methodology and Design.
Minschart C, Maes T, De Block C, Van Pottelbergh I, Myngheer N, Abrams P, Vinck W, Leuridan L, Mathieu C, Billen J, Matthys C, Weyn B, Laenen A, Bogaerts A, Benhalima K. Minschart C, et al. Among authors: vinck w. J Clin Med. 2020 Aug 13;9(8):2635. doi: 10.3390/jcm9082635. J Clin Med. 2020. PMID: 32823771 Free PMC article.
The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patients.
Pappaccogli M, Di Monaco S, Warchoł-Celińska E, Lorthioir A, Amar L, Aparicio LS, Beauloye C, Bruno RM, Chenu P, de Leeuw P, De Backer T, Delmotte P, Dika Z, Gordin D, Heuten H, Iwashima Y, Krzesinski JM, Kroon AA, Mazzolai L, Poch E, Sarafidis P, Seinturier C, Spiering W, Toubiana L, Van der Niepen P, van Twist D, Visonà A, Wautrecht JC, Witowicz H, Xu J, Prejbisz A, Januszewicz A, Azizi M, Persu A; European/International FMD Registry and Initiative (FEIRI), and the Working Group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH). Pappaccogli M, et al. Cardiovasc Res. 2021 Feb 22;117(3):950-959. doi: 10.1093/cvr/cvaa102. Cardiovasc Res. 2021. PMID: 32282921 Free article.
Pancreatic hemi-agenesis in MEN1: A clinical report.
Vinck WJ, Van de Mierop F, Van Mieghem F, Vinck M, Becq H, Michils G. Vinck WJ, et al. Eur J Med Genet. 2018 Apr;61(4):181-184. doi: 10.1016/j.ejmg.2017.11.013. Epub 2017 Nov 23. Eur J Med Genet. 2018. PMID: 29174091
Rationale and design of the Investigator-Steered Project on Intravascular Renal Denervation for Management of Drug-Resistant Hypertension (INSPiRED) trial.
Jin Y, Jacobs L, Baelen M, Thijs L, Renkin J, Hammer F, Kefer J, Petit T, Verhamme P, Janssens S, Sinnaeve P, Lengelé JP, Persu A, Staessen JA; investigator-steered project on intravascular renal denervation for management of drug-resistant hypertension (INSPiRED) investigators. Jin Y, et al. Blood Press. 2014 Jun;23(3):138-46. doi: 10.3109/08037051.2014.899297. Epub 2014 Apr 17. Blood Press. 2014. PMID: 24742341 Free PMC article. Clinical Trial.
In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions.
Mbunwe E, Van der Auwera BJ, Weets I, Van Crombrugge P, Crenier L, Coeckelberghs M, Seret N, Decochez K, Vandemeulebroucke E, Gillard P, Keymeulen B, van Schravendijk C, Wenzlau JM, Hutton JC, Pipeleers DG, Gorus FK; Belgian Diabetes Registry. Mbunwe E, et al. Diabetologia. 2013 Sep;56(9):1964-70. doi: 10.1007/s00125-013-2951-8. Epub 2013 May 28. Diabetologia. 2013. PMID: 23712485 Free PMC article.
18 results